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Abstract
Burkholderia pseudomallei, the etiologic agent of human melioidosis, is capable of causing severe acute infection with
overwhelming septicemia leading to death. A high rate of recurrent disease occurs in adult patients, most often due to
recrudescence of the initial infecting strain. Pathogen persistence and evolution during such relapsing infections are not
well understood. Bacterial cells present in the primary inoculum and in late infections may differ greatly, as has been
observed in chronic disease, or they may be genetically similar. To test these alternative models, we conducted whole-
genome comparisons of clonal primary and relapse B. pseudomallei isolates recovered six months to six years apart from
four adult Thai patients. We found differences within each of the four pairs, and some, including a 330 Kb deletion, affected
substantial portions of the genome. Many of the changes were associated with increased antibiotic resistance. We also
found evidence of positive selection for deleterious mutations in a TetR family transcriptional regulator from a set of 107
additional B. pseudomallei strains. As part of the study, we sequenced to base-pair accuracy the genome of B. pseudomallei
strain 1026b, the model used for genetic studies of B. pseudomallei pathogenesis and antibiotic resistance. Our findings
provide new insights into pathogen evolution during long-term infections and have important implications for the
development of intervention strategies to combat recurrent melioidosis.
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Introduction
Pathogenic bacteria that are able to persist in vivo face strong
selective pressure during infection leading to variations within
clonal lineages. Knowledge of genomic changes in bacteria during
prolonged infection is only slowly accumulating [1]. Several
studies have focused on comparative genomic analysis of
sequential isolates obtained from hosts with chronic infections of
Pseudomonas aeruginosa [2–4], Helicobacter pylori [5,6] and Staphylococ-
cus aureus [7]. These studies showed that bacterial adaptation
during infections involved, in part, changes in genome sequence or
content resulting in enhanced antimicrobial resistance, reduced
acute virulence and improved metabolic fitness. Although such
changes presumably favor the clonal expansion of the bacteria, the
mutations may also create new vulnerabilities that can be
exploited for treatment. In contrast to such chronic infections,
other pathogenic bacteria, e.g. Mycobacterium tuberculosis, can
establish long-term colonization with periods during which the
bacteria are in a low- or non-replicative state. Non-replicating
pathogens are more resistant to current therapeutic approaches
and require protracted treatment periods [8]. Despite the need for
better intervention strategies, comparative whole-genome analyses
of sequential isolates of such persistent bacteria have not been
conducted.
Burkholderia pseudomallei, the causative agent of the often-fatal
disease melioidosis, is capable of causing persistent infections in its
human host. This facultative intracellular pathogen can cause
acute infections, which if not completely cleared can recrudesce
months or years after the initial infection. Recurrent disease in
patients who survive a primary episode occurs in approximately
6% in the first year and in 13% within ten years [9]. A study that
evaluated recurrent disease in 116 Thai patients in terms of relapse
(same strain) or reinfection (different strain) found that 75% of
episodes were due to relapse [10]. Latent, asymptomatic infections
also occur and may progress to acute melioidosis decades after the
initial exposure to the organism [11–13]. It is not known if B.
pseudomallei exists in a dormant state between periods of active
disease. The mechanism involved in adaptation to the host niche
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36507also is largely unknown [14]. A few studies have focused on
bacterial population diversity during the acute phase of B.
pseudomallei infection [15–17], and one report of genetic variation
in the B. pseudomallei core genome noted a small number of
mutational differences between two clonal pairs of isolates [18];
however, to date there have been no investigations focused on
comparative genomic analysis of isolates associated with primary
and relapse episodes.
The aim of our research was to conduct whole-genome
comparisons of clonal primary-relapse B. pseudomallei pairs from
four adult Thai patients recovered six months to six years apart.
For comparison purposes, we included an additional pair isolated
during the same primary infection but from different body sites.
We completed a base-pair accurate genome sequence for one
isolate in this pair, 1026b (GenBank accessions CP002833-
CP002834), which has been employed extensively in laboratory
studies. Here we present all genomic changes, from single
nucleotide polymorphisms (SNPs) to large structural variants,
between isolate pairs in order to gain insights into the bacterial
genetic adaptations during persistent infection.
Results
Experimental Approach
To comprehensively investigate genetic changes in B.
pseudomallei during persistent infections, we analyzed genomic
data for clonal primary-relapse isolates collected from four
patients admitted to Sapprasithiprasong Hospital in Thailand
between 1988 and 1999 (Table 1). Clonality was initially
established with multilocus sequence typing (MLST) [19]. The
intervening periods for these pairs spanned from six months to
more than six years, a range that overlaps that of a majority of
reported relapse episodes [10]. We also analyzed genomic data
for a pair of clonal primary isolates collected from one patient
in 1993 (Table 1). These isolates were sampled from different
body sites on the day of hospital admittance and were included
in the study to provide insight into genetic changes during acute
primary infection.
We aligned raw sequence reads to reference genomes to assess
SNPs and insertions/deletions (indels) within clonal pairs. Publicly
available completed genomes for 1106a and 1710b and Sanger
sequence reads for 1106b and 1710a provided for direct
comparison of primary and relapse isolates in the 1106 and
1710 pairs. We generated sequence reads for 1026a (GenBank
accession AHJA00000000) using Illumina sequencing-by-synthesis
technology and aligned those reads to our completed 1026b
genome. We also generated Illumina reads for 1258a (GenBank
accession AHJB00000000), 1258b (GenBank accession
AHJC00000000), 354a (GenBank accession AGVS00000000)
and 354e (GenBank accession AHJD00000000), and we identified
variants unique to the primary or relapse isolate in these pairs
based on alignment of reads to the 1026b and K96243 [20]
reference sequences. All SNPs and short indels were validated by
PCR and Sanger sequencing.
To assess structural variation within clonal pairs, we employed a
fosmid cloning strategy designed to identify large-scale (.1 Kb)
differences between a query and reference genome [21,22]. A set
of fosmid clones for each isolate listed in Table 1 was aligned, or
tiled, against the appropriate reference sequence to reveal
insertions, deletions, inversions and translocations. Self-tilings,
such as 1026b fosmids tiled against the 1026b reference sequence,
served as controls, and in this particular example, also aided with
validation of the completed 1026b sequence.
Genome Sequence of the B. pseudomallei 1026b
Reference Strain
B. pseudomallei 1026b was isolated from a 29-year-old female
patient with septicemic melioidosis with skin, soft tissue, spleen and
joint involvement (Table 1). The strain has become a model for
genetic analysis of B. pseudomallei due to its high efficiency of
transformation and overall ease of genetic manipulation [23,24].
An attenuated strain suitable for biosafety level 2 (BSL2)
manipulation also has been constructed [25]. Strain 1026b is the
fifth B. pseudomallei clinical isolate to be sequenced to base-pair
accuracy (www.ncbi.nlm.nih.gov/). We annotated the 1026b
sequence and compared it to four completed and nine draft B.
pseudomallei genomes using the Prokaryotic Genome Analysis Tool
(http://tools.nwrce.org/pgat/) [26]. We found that 1026b was
similar to the others with respect to genome size and structure,
number of predicted genes and other attributes (Figure 1, Table S1
and Table S2). Of the 6070 total predicted genes in 1026b, 4705
(77%) were present in all 13 of the other genomes, 1330 (22%)
were shared by a subset, and 35 (1%) coding primarily phage and
hypothetical proteins were unique to 1026b (Table S3). The
number of core genes is comparable to the 4908 identified by
Nandi et al. [18] for a partially overlapping set of 11 genomes, and
the difference is likely due to the larger number of draft quality
genomes in our data set. When compared to just the four other
completed B. pseudomallei genomes (Table S2), there were 31 genes
that were present in those strains but were missing or interrupted
(pseudogenes) in 1026b (Table S3). In addition to hypothetical
proteins, this list includes the entire K96243 genomic island (GI) 1
and the gene encoding the signal transduction histidine kinase
IrlS2.
We identified 17 GIs in the 1026b genome (Table 2), including
the functional prophage phi1026b [27]. Ten GIs are shared at
least in part by one or more of the other four completed genomes,
including five islands that were described in K96243 [20]. Two
additional K96243 islands (GI7 and GI14) that were present in all
94 B. pseudomallei strains evaluated by Sim et al. using a K96243-
based DNA microarray [28] are present in the 1026b genome and
are considered to be part of the core genome, following their
suggestion. Of the seven islands not found in other completed
genomes, two contain genes for XRE family transcriptional
regulator proteins, one contains a putative ATP binding protein
gene and four contain genes encoding prophage and/or hypo-
thetical proteins. In addition to the GIs identified in our study,
1026b contains 16 of the 20 novel indels identified by Sim et al.,
where novel was defined as the absence of at least three contiguous
probes in at least three of their 94 strains [28]. The 1026b genome
is missing all genes in indels 1 and 2, which encode hypothetical
and phage proteins. It also is missing most genes in indels 4 and
11, with the exception of a homolog of an exported protein (gene
locus BPSL2038 in K96243) and a pseudogene of pANL56
(BPSS0395) from those two indels, respectively.
The characteristic composition and organization of this genome
substantiates the use of 1026b as the representative B. pseudomallei
isolate for laboratory studies.
Comparison of 1026a and 1026b Primary Isolates
The 1026a and 1026b isolates were collected from pus and
blood, respectively, 14 days after the onset of symptoms (Table 1).
Based on the data we collected, the genomes of these two primary
isolates were identical (Table 3).
Three previous studies based on more limited data investigated
genetic changes among B. pseudomallei isolates during acute
infections. In their study of four acute Thai cases, Price et al.
reported that roughly 70% of isolates were identical to that of
Evolution of B. pseudomallei
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loci, while 30% were observed to have on average one or two
repeat copy number changes [17]. These VNTR regions span
simple sequence repeats (SSRs), which are tandem arrays of short
sequences that gain or lose repeat units by recombination or
slipped-strand mispairing during DNA replication [29]. The B.
pseudomallei genome contains a large number of SSRs relative to
other bacterial pathogens of similar genome size and GC content
[30,31], and Price et al. demonstrated that the in vitro mutation
rate of these sites in B. pseudomallei is high relative to SSRs in
Yersinia pestis and E. coli [17]. Pearson et al. found a similar amount
of VNTR variation among isolates collected from an Australian
patient with fatal septicemic melioidosis [15]. Sam et al. studied
five B. pseudomallei isolates sampled from a single Malayan patient
at days 1 (3 isolates), 9 (1 isolate) and 17 (1 isolate) of admission,
during which he was treated with ceftazidime [16]. They identified
a single amino acid change in the class A b-lactamase gene penA in
two isolates from day 1 and one isolate from day 17 that conferred
increased resistance to ceftazidime and increased susceptibility to
amoxicillin-clavulanate.
These studies suggest that genetic changes occur in subpopu-
lations of B. pseudomallei during acute infections; thus, the lack of
variation observed between 1026a and 1026b may be the result of
limited sampling that fails to detect changes, especially rare events,
in the infection. Certain changes, particularly those at VNTR loci,
may be unrelated to bacterial fitness, while others, such as penA
mutations, are adaptive in response to treatment regimes. This
pattern of change for acute primary disease provided a basis for
understanding the mutational process in recurrent melioidosis.
Indels are the Most Abundant Form of Genomic Variation
Among Primary-relapse Pairs
We found 57 indels among three of the four primary-relapse
pairs (Table 3); 33 were intergenic and 24 were located in coding
sequence (Table S4). No indels were found in 1258a-1258b, the
pair with the shortest time interval between isolates. All indels,
regardless of being located in coding or intergenic sequence,
occurred in SSRs. Pairwise comparisons revealed one recurrent
variant in the 1106 and 1710 pairs that did not change the amino
acid sequence of a hypothetical protein (Table S4). In the 1106
and 1710 pairs, indels in coding regions were almost evenly split
between chromosome 1 and chromosome 2, and between
insertions and deletions, while in 354a-354e they were restricted
to deletions in chromosome 2 (Table S4).
In-frame (3 bp triplet) insertions and deletions altered the
number of amino acid repeats in the relapse isolate relative to the
primary isolate. Indels involving non-triplet repeat motifs had
various consequences. Frameshifts occurring within the first
quarter to third of the protein, which presumably disrupt protein
function, were most abundant. In the 1106 and 1710 pairs, all
predicted frameshifts in the relapse isolate occurred in proteins
annotated solely as hypothetical, except frameshifts in two known
genes that may be the result of start codon misassignment (Table
S4). In the 354 pair, frameshifts occurred near the start of a short-
chain dehydrogenase gene locate immediately downstream of folE
involved in folate biosynthesis, and in the gene encoding lipase-like
protein LlpE that is located between the BpeEF-OprC drug efflux
system and its LysR type regulator BpeT. In addition to
frameshifts, we found insertions in 1106b near the end of open
reading frames that resulted in: 1) no apparent changes to the
amino acid sequence, 2) non-synonymous substitutions with no
alteration in the length of the protein, or 3) non-synonymous
substitutions resulting in removal of the stop codon. In the last
case, the protein, annotated as an AraC family transcriptional
regulator, is extended by 94 amino acids.
Given the very high SSR mutation rate in B. pseudomallei
[15,17,30] and the preponderance of changes in intergenic
regions, much of the observed variation is likely to be selectively
Figure 1. Schematic circular diagrams of the large and small chromosomes of the 1026b genome. Rings from outside to inside: scale
with tick marks positioned every 200 Kb, annotated forward CDS and reverse CDS colored-coded by COG functional categories (Table S1),
pseudogenes (olive), genomic islands (red), IS elements (blue), rRNA and tRNA (green), GC% plot and (G – C)/(G + C) deviation plot.
doi:10.1371/journal.pone.0036507.g001
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changes in amino acid repeat units has been observed previously
in B. pseudomallei and has been implicated in phase variation, the
process by which genes undergo reversible mutations and generate
phenotypic diversity in clonal populations [31,32]. Interestingly,
variable copy numbers of the in-frame repeat units listed in Table
S4 were found in the same genes in unrelated B. pseudomallei strains
with publicly available sequences (not shown); however, the
functional significance of these changes remains unknown. Further
experiments are also required to understand the phenotypic
consequences of observed frameshifts in coding regions. The
frameshift in LlpE is particularly intriguing, since we also found a
structural variant within the BpeEF-OprC operon of 354e as
described below.
Point Mutations Indicate Variation within Single
Infections of B. pseudomallei in Two Melioidosis Patients
Despite varying time intervals between primary and relapse
isolates (Table 1) and different methods of SNP detection (see
Materials and Methods), the number of point mutations within
clonal pairs ranged from zero to eight. These results are consistent
with the observed number of SNPs in the 1710 and 1106 pairs
made by Nandi et al. [18], although their list contains errors in the
1710b and 1106a reference sequences (consensus bases not
supported by Sanger or Illumina reads, Table S5) that could not
be identified as such by their methods. Of the fifteen SNPs
identified in the 1710, 1106 and 354 pairs, thirteen occurred in
coding sequence (Table 4). Eight resulted in nonsynonymous (NS)
changes, and seven of these occurred in genes with known or
putative functions. Five NS changes were predicted to be
deleterious by the ‘‘Sorting Intolerant from Tolerant’’ (SIFT)
algorithm, which computationally predicts whether an amino acid
substitution will be deleterious (D) or tolerated (T) for protein
function [33]. Of particular note were two mutations that were
present in primary isolates but absent from the associated relapse
strains. The synonymous mutation in the CobN gene of 354a was
unique relative to 354e and all other Burkholderia strains in
BLASTN alignments. Similarly, the NS mutation in the TetR
family transcriptional regulator protein of 1710a was unique
relative to 1710b and all other Burkholderia strains in BLASTP
alignments. While it is possible that these SNPs were not found in
relapse isolates due to reversion of nucleotide changes, a more
parsimonious explanation is that the primary and relapse isolates
were sampled from divergent lineages of the bacterial infection.
Variation in single melioidosis infections has been observed
previously [15,17]. As discussed below, we found more evidence
for lineage heterogeneity from additional SNP discovery and
analysis of structural variants.
Mutations in a TetR Family Transcriptional Regulator
Reveal Adaptation of B. pseudomallei in Clinical Isolates
Pairwise comparison of all SNPs showed recurrent mutations in
homologs of the TetR family transcriptional regulator BPSS1483
in 1710a and 354e (Table 4). Mutations were identified at different
positions, but in both isolates the SNP occurred early in the
protein at highly conserved residues [34]. TetR family proteins are
transcriptional repressors that control genes whose products are
involved in multidrug resistance, biosynthesis of antibiotics,
osmotic stress, pathogenicity and various catabolic pathways in
gram-negative and gram-positive bacteria. The discovery of two
independent NS mutations in the same TetR family regulator
prompted us to investigate the sequence of this gene in additional
B. pseudomallei isolates. We screened for mutations in homologs of
BPSS1483 in 107 strains from Thailand, Australia, Pakistan,
Singapore and Vietnam (Table S6). This list included 32 clonal
primary-relapse pairs and eight environmental strains. We found
22 sites with NS mutations in 18 clinical isolates. Nearly half of
these mutations occurred in primary-relapse pairs; none were
found in any of the environmental strains (Table 5). We found
eight sites with synonymous changes in a total of nine isolates
(Table S7).
Similar to most prokaryotic transcriptional regulators, TetR
family proteins possess helix-turn-helix (HTH) DNA-binding
motifs, which in TetR proteins are located in the N-terminal
region and show a high degree of sequence conservation among
family members [34]. All NS mutations found in the first half of
the gene introduced either a stop codon or an amino acid that was
predicted to be deleterious to protein function (Table 5). In
addition, we found a single base pair deletion at position 448 in a
primary isolate with no associated relapse that caused a frameshift
in the coding sequence (not shown). The second half of the gene
contains SSRs and numerous strains had trinucleotide-based
indels relative to the K96243 reference sequence, which
introduced alignment gaps. As a result, predictions of amino acid
changes on protein function were not possible here. Nonetheless, it
is interesting that most of these mutations were found in strains
from Australia, e.g. 668, 305 and 1655. Australian and Asian
strains have been shown to be genetically distinct [18,35]; thus,
these SNPs may simply reflect geographical differences. It is also
interesting that NS changes here are shared by primary and
relapse isolates of clonal pairs, e.g. 1119, 1210 and 658. This is in
contrast to the deleterious changes in the first half of the gene,
most of which were found in only the relapse isolate of a given
pair.
For comparison, we searched for NS SNPs in 20 additional
genes annotated as TetR family regulators in 20 publicly available
B. pseudomallei genomes, including one environmental strain. We
found ten genes with #1 NS SNP, eight with 3–6 NS SNPs and
two with .6 (10 and 17) NS changes (not shown). In this set of
genomes there were 10 NS changes in BPSS1483. The environ-
mental strain, B. pseudomallei S13, had single NS SNPs in two
regulators, both of which occurred within the final ten amino acids
of the proteins, were shared with at least two other strains and
were predicted to be tolerated or were in a region where
predictions were not possible. Taken together, it appears that
BPSS1483 homologs experience a relatively high rate of NS
substitutions compared to most other TetR transcriptional
regulators.
The 59 end of BPSS1483 is likely crucial for function, as
suggested by the high level of sequence conservation among TetR
family members and the presence of identifiable domains. While
synonymous and non-synonymous substitutions were evenly
distributed across the gene, the conserved 59 region contained
Table 3. Summary of whole genome variation in the five B.
pseudomallei isolate pairs.
Isolate pairs # SNPs # Indels Structural variants Chromosome
1026a-1026b 0 0 None -
1258a-1258b 0 0 330 Kb Deletion 2*
1710a-1710b 2 14 22 Kb Tandem repeat 2*
1106a-1106b 5 41 None -
354a-354e 8 2 800 Kb Inversion 2*
*1258a, 1710a and 354e exhibited the structural variant noted.
doi:10.1371/journal.pone.0036507.t003
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clinical isolates. Although the data set was not amenable to dN/dS
calculation, the density of deleterious changes in this region and
this group of strains, combined with the high rate of NS
substitutions in BPSS1483 homologs relative to other TetR
transcriptional regulators, lead us to speculate that there is positive
selection for coding changes in this gene and that it may play an
adaptive role in vivo.
BPSS1483 Homologs are Present in Other Pathogens but
the Gene does not Affect Antibiotic Susceptibility
Little is known about BPSS1483 beyond being annotated as
encoding a TetR family protein. A search for the gene in the
STRING database [36] showed that synteny of BPSS1483 with
the adjacent and divergently oriented hypothetical proteins
BPSS1484, BPSS1485 and BPSS1486 is preserved in strains of
B. pseudomallei and its close relatives B. mallei and B. thailandensis.
Syntenic homologs of these four genes also were found in the
pathogens Bordetella pertussis, B. parapertussis and B. bronchiseptica, and
syntenic homologs of BPSS1483, BPSS1484 and BPSS1485 were
identified in the human pathogens Yersinia pestis and Y. enterocolitica,
and several plant and insect pathogens or endosymbionts,
including Erwinia carotovora, Photorhabdus luminescens and Rhizobium
leguminosarum. The Bordetella and E. carotovora genomes possess 15 or
more TetR proteins, while the Y. pestis and P. luminescens genomes
contain only 6–8 [34]. The presence of this putative BPSS1483
operon in numerous pathogens and symbionts, especially among
the relatively small number of tetR-related genes in Y. pestis and
P. luminescens genomes, supports the hypothesis that these genes
contribute to the ability of bacteria to survive in vivo.
Since TetR regulators are sometimes involved in antibiotic
resistance, we tested the susceptibility of three B. pseudomallei and
three B. thailandensis strains to ten antimicrobial compounds
(Table 6). The B. pseudomallei strains included 1026b, 354b and
354e. The 354b isolate was collected during the primary infection
three months after the 354a isolate, which could not be recovered
in culture. The sequence of the BPSS1483 homolog from 354b
was identical to that of 354a. The B. thailandensis strains included
the sequenced reference strain E264 and two transposon insertion
mutants from a B. thailandensis E264 sequence-defined transposon
mutant library (L. Gallagher and B. Ramage, pers. comm.).
TnBTH_II0885 has a transposon insertion in the BPSS1483
homolog. TnBTH_I3273 has an insertion in a transposase gene
and was included as an insertion mutant control (see Methods and
Materials). B. thailandensis has been used as a surrogate for studying
many different traits in B. pseudomallei [37,38], since it can be
manipulated under BSL2 laboratory conditions and has no
restrictions on use of antibiotic resistance markers for research.
These mutants carry a tetracycline resistance gene and were
expected to have high MICs for this compound.
The most striking result of the susceptibility test was the high
MICs displayed by 354e relative to the other strains. In particular,
resistance increased .21-fold and .10-fold to chloramphenicol
and ofloxacin, respectively, and nearly 8-fold to trimethoprim/
sulfamethoxazole compared to the primary isolate. The
TnBTH_II0885 mutant did not exhibit a similar resistance
phenotype, suggesting that something other than the BPSS1483
mutation in 354e accounted for reduced susceptibility to these
antimicrobials. As discussed below, 354e has an inversion in
chromosome 2 that interrupts the BpeT regulator of the BpeEF-
OprC drug efflux operon, which has been shown to efflux
Table 4. SNPs found in the 354, 1106 and 1710 isolate pairs.
Reference locus Isolate
S/
NS AA
AA in
Burkholderia spp. AA/Total SIFT
# Gene product Protein function
BPSL0042 354e NS Cys Arg 361/670 T Type III DNA modification methyltransferase Defense mechanism
BPSL1768 354a S - 1107/1281 - Cobaltochelatase (CobN) Vitamin B12
metabolism
BPSL2301 1710b S - 35/898 - Pyruvate dehydrogenase subunit E1 (AceE) Energy production
BPSL2706 354e NS Lys Thr 271/532 D Putative lipoprotein -
BPSL3027 1106b S - 142/504 - DP-N-acetylmuramoyl-L-alanyl-D-glutamate
synthase (MurD)
Cell envelope
biogenesis
BPSL3288 354e NS Leu Pro 216/276 D 5,10-methylenetetrahydrofolate reductase
(MetF)
Methionine
metabolism
BPSL3389 1106b NS Val Ala 886/1309 D Trifunctional transcriptional regulator/proline
dehydrogenase (PutA)
Energy production
BPSL3390 1106b S - 645/780 - Primosome assembly protein (PriA) DNA replication
BPSS0289* 354e - - - - - Hypothetical protein -
BPSS0571 1106b S - 76/117 - Hypothetical protein -
BPSS0946
+ 354e - - - - - b-lactamase (PenA) Defense mechanism
BURPS1106A_1241 1106b NS His Arg 45/178 - Hypothetical protein -
BPSS1483 354e NS Phe Leu 41/344 D TetR family protein Transcriptional
regulation
BPSS1483 1710a NS Asp Tyr 53/344 D TetR family protein Transcriptional
regulation
BPSS1995 354e NS Thr Ala 58/475 T Signal transduction histidine kinase (IrlS2) Signal transduction
*SNP is located 112 bp upstream of BPSS0289.
+SNP is located 78 bp upstream of penA.
#SNPs are predicted to be deleterious (D) or tolerated (T) with regard to protein function.
doi:10.1371/journal.pone.0036507.t004
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SNP in 354e located 78 bp upstream of the b-lactamase gene penA
(Table 4) known to mediate b-lactam resistance in B. pseudomallei
[40], which may play a role in its reduced susceptibility to those
compounds in our panel.
Structural Variants Provide Further Evidence for Lineage
Heterogeneity and Adaptation During Infection
In three of the four primary-relapse pairs, we found large
structural variants of chromosome 2 that interrupted otherwise
syntenic primary and relapse replicons (Table 3). In the 354 pair
Table 5. Nonsynonymous mutations in BPSS1483 homologs from 107 B. pseudomallei isolates.
Nucleotide change Amino acid change Strain
Present in
primary
Present in
relapse
+
Predicted effect on protein
function
#
C70T Q24Stop 770 N Y Stop
C160T R54C 242, 1350* N, N Y, Y D
T185G L62R 1428* N Y D
G307T E103Stop 1686* N Y Stop
G351A W117Stop 479 N Y Stop
G358T E120Stop 479 Y N Stop
T500C L167P Pakistan 9 Y - D
G539A W180Stop 986a Y - Stop
C647T A216V 668 Y - -
C686T A229V 1655 Y - -
C691G Q231E 1119, 1210, 1069c Y, Y, Y Y, Y, - -
G695A, C696T G232D 1119, 1210, 1069c Y, Y, Y Y, Y, - -
G703C E235Q 668, 305 Y - -
A709G T237A 668 Y - -
G712A A238T 305, 1069c Y, Y -, - -
G838A G280S 668, 406e, Pasteur 52237, 1373c Y, Y, Y, Y -, -, -, - -
A893G, T894C D297G 1069c Y - -
C904T P302S 658 Y Y -
C973T P325S 668, 305 Y, Y -, - -
T979A S327T 305 Y - -
C982T S328P 305 Y - -
A988G T330G 305 Y - -
*Sequence chromatograms showed peaks for both the reference and SNP bases at this position in relapse isolates.
+For isogenic pairs only.
#SNPs introduced a stop codon (Stop) or were predicted to be deleterious (D) with regard to protein function. Prediction was not possible in the second half of the
gene due to gaps in sequence alignments.
doi:10.1371/journal.pone.0036507.t005
Table 6. Antibiotic susceptibility of B. pseudomallei and B. thailandensis strains.
MIC (ug/ml)
TZ CL IP MC MP OF PP TC TS XL
B. pseudomallei strains
1026b 1.5 8 0.38 0.75 1.5 2 1 1.5 0.25 1
354b 2 12 0.5 1.5 1.5 3 2 2 0.38 2
354e 6 .256* 1.5 6 6 .3 2 * 4434
B. thailandensis strains
E264 1.5 8 0.38 1 1 1.5 2 3 0.75 3
TnBTH_I3273 1.5 8 0.38 4 1 3 2 64 1.5 3
TnBTH_II0885 1.5 8 0.38 2 1 1.5 2 64 1.5 6
Antimicrobial agent abbreviations: TZ, ceftazidime; CL, chloramphenicol; IP, imipenem; MC, minocycline; MP, meropenem; OF, ofloxacin; PP, piperacillin; TC, tetracycline;
TS, trimethoprim/sulfamethoxazole (1/19); and XL, amoxicillin/clavulanic acid (2/1). For TS and XL, numbers in parentheses indicate the ratio of drugs in the
combination, and the MIC value refers to the first component.
*Detection limits of the assays.
doi:10.1371/journal.pone.0036507.t006
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primary isolate and other complete B. pseudomallei genomes (not
shown). The inverted segment of DNA contains the origin of
replication. One breakpoint is located in a transposase gene
homologous to BPSS2046, and the other is located in the C-
terminal region of the homolog of BpeT, the regulator of the
BpeEF-OprC drug efflux system. This rearrangement of chromo-
some 2 may contribute to reduced susceptibility of 354e to
chloramphenicol and trimethoprim as discussed above. Inversions
of this size have been observed in chromosome 1 of several B.
pseudomallei strains, including K96243, 1655, Pasteur52237 and
406e [18]; however, this is the first report of such an inversion in
chromosome 2.
In the 1258 pair we found a 330 Kb deletion in chromosome
2 of the primary isolate relative to the relapse isolate and other
complete B. pseudomallei genomes (Figure 2). This is the only
genomic variation that we found in this isolate pair, i.e. the
primary and relapse genomes are otherwise identical based on
the data we collected. One end of this large deletion is located
intergenically between homologs for a putative lipoprotein
(BPSS1249) and acetylpolyamine aminohydrolase (BPSS1250)
and the other is located within BPSS1483 resulting in the
deletion of nearly 40% of this tetR-related gene. This deletion
removed 232 complete genes (homologs of BPSS1250-BPSS1482)
from chromosome 2 of 1258a totaling 10% of the replicon. The
deleted genes are part of a highly syntenic region of the core B.
pseudomallei genome supporting the notion that DNA was lost
from 1258a rather than gained by 1258b. Given that 1258a and
1258b are clearly clonal, a reasonable scenario is that the patient
contained at least two lineages, one with and one without the
deletion, at the time the primary isolate was collected. During
relapse, only the isolate without the deletion remained, or was
sampled. Accordingly, we believe that this deletion is another
example of genetic heterogeneity within a single infection of B.
pseudomallei.
The most intriguing structural variant identified in our study
was found in the primary isolate of the 1710 pair relative to the
relapse isolate and other completed B. pseudomallei genomes. In this
isolate we found a tandem repeat comprised of a 22 Kb region of
chromosome 2. The depth of coverage of 1710a Sanger sequence
reads and fosmids aligned to the 1710b reference sequence in this
region was approximately 7 and 12 times the average, respectively
(Figure 3). We estimated that there were likely closer to 7 copies in
the repeat based on limitations of fosmid tiling; however, the exact
copy number in the repeat was not elucidated, since the repeat size
confounded sequence finishing. The repeat spanned 17 genes,
extending from a gene encoding a rearrangement hot spot (Rhs)
element Vgr protein to a gene encoding a terpene synthase family
protein (Table S8). Among the 17 genes was a penicillin-binding
protein (PBP) (BPSS1219) whose deletion has been associated with
resistance to ceftazidime [41]. Amplifications of PBP genes also
have been shown to increase b-lactam resistance [42], e.g.
overproduction of the related PBP3 in Pseudomonas aeruginosa has
been linked to reduced susceptibility to this class of compounds
[43]. Thus, it is reasonable to hypothesize that amplification of this
gene in 1710a was a result of antibiotic selective pressure, as
ceftazidime has been used as first line parenteral therapy in
Thailand since 1989 [44].
Discussion
In this whole-genome study of sequential B. pseudomallei clinical
isolates, we described the extent of genetic variation from SNPs
and indels to large-scale structural changes. There were notable
patterns among the pairs. We discovered nucleotide changes and
structural variants in primary isolates that were absent from
associated relapse isolates and identified genomic changes in both
primary and relapse isolates that likely increased resistance to
antimicrobials administered for treatment. We also identified
recurrent deleterious mutations in a TetR family transcriptional
regulator that may promote survival in vivo. It is unlikely that these
observed variations were due to reinfection of patients with strains
of different genotypes. The paired isolates are unambiguously
clonal, and the chance is very low of infection months or years
later by the same clone given the vast diversity of strains found in
the environment [45]. It is likely that some variation existed within
the population of cells that comprised the early stages of infection.
Given observed mutation rates of VNTR loci [17,30], some
diversity in SSR lengths could be expected, especially for repeats
in non-coding regions. However, outside SSRs, it is most likely
that the observed changes were selected for in the host. The
strongest evidence for this comes from variation in the TetR family
repressor, which showed evidence of negative selection for its
function in relapse clinical isolates despite conservation of
homologs across an array of plant and animal pathogens. Further
evidence comes from observed variations in or near genes involved
in antibiotic resistance mechanisms, such as multidrug efflux
pumps, penicillin-binding proteins and b-lactamases. Taken
together, our results reveal the presence of multiple genotypes
within a single infection that are, at least in part, the result of
genetic adaptation to the human host.
Among our four primary-relapse pairs, we did not detect the
loss of virulence factors as has been reported in studies of
sequential isolates from chronic infections of Pseudomonas aeruginosa
[2,4]. We speculate that bacteria that cause a relapse episode after
the patient is apparently cured may be responding to a different set
of selection pressures than those involved in chronic disease.
Although little is known about the long-term persistence of B.
pseudomallei in vivo, the bacterium has been shown to quiescently
persist in vitro. Pumpuang et al. recently demonstrated survival of
B. pseudomallei in distilled water for 16 years [46]. They found that
the number of live organisms estimated by viability staining was
higher than that seen from a colony count on agar, which
suggested a proportion of the surviving cells were non-culturable
under standard conditions, perhaps due to being in a non-
replicating state. Also recently, Hamad et al. showed that under
anaerobic conditions, a small proportion of the B. pseudomallei
population maintained complete viability for at least one year in
an apparently dormant state and was sensitive to drugs used
against anaerobic pathogens but not to traditional melioidosis
antibacterials [47]. They likened this persister population to those
found in other bacteria, such as Mycobacterium tuberculosis that can
cause recurrent infections due to relapse. Incidentally, analysis of
IS6110 DNA patterns in clonal M. tuberculosis strains separated by
30 years showed stability compared to patterns in active disease,
demonstrating that these persistent bacteria were not actively
replicating [48]. The existence of a non- or slow-replicating state
during persistent infections may be key to the types of genomic
changes observed.
The amount of genetic variation observed across the four
primary-relapse pairs was relatively consistent, and the number
of SNPs increased as time between primary and relapse isolates
increased (Table 3). With the exception of SNPs in BPSS1483
homologs and one recurrent indel in a hypothetical protein,
there was no overlap in mutations across isolates. This may be
explained by three non-mutually exclusive possibilities: 1) we did
not find all the existing variation in our isolate pairs, 2) our
sample size was too small, especially for detecting rare variants,
Evolution of B. pseudomallei
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Detection of indels in SSRs longer than the length produced by
current short read sequencing technologies is difficult. Similarly,
detecting SNPs in repeat regions can be difficult due to poor
sequence read mapping. Our fosmid-based method for identi-
fying structural variation has size limitations as well [21].
Despite these shortcomings, it is reasonable to believe that we
found most of the existing variation given our mix of sequence
data types and analysis methods and the fact that our results are
consistent with a previous study [18]. Recurrent mutations in
genes such as penA documented in multiple non-clonal strains
elsewhere [16,49] were not recurrent in our dataset. Our
sampling allowed us to uncover a portion of the genetic
variation in four independent infections. We recognize that
more than two isolates are required to fully characterize the
evolution of B. pseudomallei over the course of a single infection
and anticipate that a study sampling several isolates at each
time point would uncover more commonly mutated genes.
(Price et al. [17] sampled ten colonies from four to seven tissue
sites per patient in their VNTR-based study of acute
melioidosis.) While B. pseudomallei strains have been shown to
differ in their individual ability to cause disease [50], variation
in the immune status and response of the infected human host
clearly affects outcome [51]. These host differences may exert
diverse selection pressures on the bacterium. It has been shown
in patients deliberately colonized with asymptomatic bacteriuria
E. coli that in addition to stochastic events, adaptive bacterial
evolution was driven by individual host environments [52].
Additionally, since our isolate pairs were collected from different
body sites, we cannot rule out the possibility that tissue-specific
selection pressures exist.
Relapse has long been recognized as a potential problem in
patients who survive acute melioidosis. While some clinical
determinants of relapse are known, such as choice and duration
of oral antimicrobial therapy [53], bacterial mechanisms contrib-
uting to persistent infections are poorly understood. Our results
are consistent with a model involving adaptation during acute
primary and relapse episodes with an intervening period of
dormancy. Adaptive changes are often associated with increased
antibiotic resistance, which may contribute to re-emergence.
Indeed, documented relapse cases have been caused by isolates
with acquired antibiotic resistance [54–56]. For patients who
survive their primary episode, the single most serious complication
is recurrent melioidosis after having an apparent cure [57]. As
improved treatment results in a greater number of patients who
survive primary infections, relapse will continue to be an
important problem.
Sequencing platforms with low costs per raw base-call have
made it practical to use deep sequence sampling to assess bacterial
evolution in a clinical setting. The whole genome sequencing and
analysis approaches used in our study provided the means for
uncovering the extent of genomic diversity in B. pseudomallei
Figure 2. Fosmid tilings from 1258a and 1258b spanning the location of the 330 Kb deletion. Tilings of 1258a (top) and 1258b (bottom)
fosmids against the 1026b reference genome as shown. Sequence coordinates of 1026b chromosome 2 appear along the top horizontal line below
which three black lines indicate 1x, 2x and 3x fosmid coverage. Two additional horizontal black lines visually separate coverage lines from clone
positions, which are represented by rectangles. Four colors within each rectangle illustrate features of the clone position as described in Hayden et al.
[21]. Blue dots at the lower left and right edges of rectangles symbolize the x and y fosmid paired-end sequences aligned to the 1026b sequence. In
1258a, five clones (yellow first quarter) spanned the deletion breakpoint and flanked a large coverage gap in the tiling. The x (at 2.0 Mb) and y (at
1.7 Mb) anchored positions of a single clone are circled. In contrast, clones from 1258b tiled throughout this region indicating that there is no
deletion in this isolate.
doi:10.1371/journal.pone.0036507.g002
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methods. Further insight into recurrent melioidosis, as well as
acute and chronic disease, will come from sequencing a larger set
of sequential isolates from individual patients. Understanding the
full extent of genetic changes in the pathogen as it infects and
resides in the host should aid the development of better
intervention strategies.
Materials and Methods
Bacterial Isolates and Genomic DNA Isolation
The ten B. pseudomallei isolates used for whole-genome
comparison are listed in Table 1, and the 107 isolates investigated
for BPSS1483 variants are listed in Table S6. Isolates were
collected as described in Maharjan et al. [10]. Relapse was defined
as the development of new symptoms and signs of infection in
association with a positive B. pseudomallei culture after an initial
response to therapy [52].
Genomic DNA for Illumina sequencing and SNP discovery in
BPSS1483 homologs was isolated using the Gentra Puregene
Yeast/Bact. Kit (Qiagen, Valencia, CA) according to manufac-
turer’s directions. The lysis step was conducted in the CDC select
agent certified BSL3 containment facility at the University of
Washington and the lysates were quarantined for 72 hours until
sterility was confirmed.
Whole-genome Sequencing of the B. pseudomallei 1026b
Reference Strain
B. pseudomallei 1026b was sequenced to completion using
standard capillary DNA shotgun sequencing protocols and data
collection tools [58]. Sequences were assembled and viewed using
Phred/Phrap/Consed software [59–61]. The quality and conti-
guity of the shotgun data were improved by three rounds of
experiments designed by the Autofinish tool in Consed [62],
followed by directed finishing experiments. The final gap in
chromosome 1 was located in the third of the three rDNA
operons. This gap was artificially closed by copying and inserting
5,344 bases from the upstream rDNA operon (2,556,685–
2,562,028). The final gap in chromosome 2, which spanned the
polyketide synthase locus PksL (BP1026B_II1104), was closed by
independent assembly in the program Sequencher (Gene Codes,
Ann Arbor, MI) of a 34 Kb contig composed of shotgun and
directed sequencing reads from this region.
Both fosmid DNA fingerprints and Illumina short-read
sequence data validated to base-pair accuracy the final 1026b
genome assembly, which contained approximately 125,000
capillary sequencing reads. Fosmid fingerprints from EcoRI, MluI
and PstI digestions were compared with the virtual sequence-
derived fragments of the final assembly using sequence-validation
features of Genomic Variation Analysis software [21]. Fingerprints
for 1503 fosmids, providing nearly continuous 2X genome
coverage of both chromosomes, corresponded to those of the final
assembly. A total of 13 million paired-end 76 base reads were
generated for the 1026b genome following manufacturer’s
protocols (Illumina, San Diego, CA). Reads were mapped to the
final sequence for the two 1026b chromosomes using MAQ [63]
and discrepancies in the alignment were manually checked in
Consed. The alignment, in which 99.78% of 1026b genome was
covered by three or more reads, confirmed base calls from the
capillary sequence data, except in regions with no Illumina read
coverage.
Figure 3. Depth of coverage of 1710a Sanger sequence reads and fosmids across chromosome 2. The number of 1710a sequence reads
(red) and fosmids (blue) was counted in 500 bp and 10 Kb sliding windows, respectively, along chromosome 2 of the complete 1710b reference
sequence. The spike in coverage of fosmids and sequence reads between 200 and 400 Kb is due to the tandem repeat of 17 genes. The smaller spike
of sequence reads between 1800 and 2000 Kb is the result of a repeat of the Rhs element Vgr protein gene BURPS1710b_A0207.
doi:10.1371/journal.pone.0036507.g003
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and 1026a
The genomes of 354a, 354e, 1258a, 1258b and 1026a were
sequenced with the Illumina Genome Analyzer according to
manufacturer’s instructions (Illumina, San Diego, CA). For each
genome a random-fragment library was constructed using a
custom paired-end protocol. Briefly, genomic DNA samples were
sheared using a Biorupter UCD-200 (Diagenode Inc., Denville,
NJ) and end-repaired. Repaired fragments were subjected to A-
tailing using Taq DNA polymerase, and custom ‘‘Y’’ adaptors
produced by hybridization of partially complimentary sequences
were ligated to A-tailed fragments using T4 DNA ligase. Two
adaptor oligonucleotides were employed: 1) PE_Adapt_hi (/
5Phos/GATCGGAAGAGCGGTTCAGCAGGAATGCCGAG),
and 2) PE_Adapt_lo (ACACTCTTTCCCTACAC-
GACGCTCTTCCGATC*T), in which the asterisk indicates
phosphorthiolation of the 39-most base.
Reads for each isolate were mapped to the 1026b and K95243
reference genomes using the Burrows-Wheeler Aligner (BWA)
program [64] in order to generate ungapped and gapped
alignments for SNP and indel calling, respectively. SNPs were
called using SAMtools [65]. SNPs in the raw pileup files for 354a
and 354e and for 1258a and 1258b were compared to identify
variants unique to the primary or relapse isolate in each pair. The
list of unique SNPs for each strain was then filtered to require $5
reads and a SNP quality $10 and to eliminate positions with
ambiguous consensus calls. Indels were called using the Genome
Analysis Toolkit (GATK) whole genome, deep coverage pipeline
with default parameters [66]. Prior to running GATK, reads were
filtered for duplicates using Picard MarkDuplicates (http://
samtools.sourceforge.net/) such that only the read pair having
the highest sum of base qualities at any given start position and
orientation was retained.
All resulting SNPs and indels were viewed in the Integrative
Genomics Viewer v1.5 [67] to eliminate false positives. Selected
variants were the major allele in one isolate of the clonal pair and
were absent, or if present were the minor allele represented by
,1% of reads, in the other isolate.
Detecting SNPs, Indels and Reference Sequence Errors in
1106a-1106b and 1710a-1710b
Traces of Sanger reads for the 1106a, 1106b, 1710a and
1710b genomes were downloaded from the Trace Archive
(www.ncbi.nlm.nih.gov/Traces/trace.cgi) and aligned to the
complete, publicly-available 1106a or 1710b genomes using
Phred/Phrap/Consed software. All high quality discrepancies
and questionable consensus bases were manually checked and
were included in the final count of SNPs and indels when a
majority of reads (Q20 or greater) in the inter-isolate
comparison, e.g. 1106b reads aligned to the 1106a genome,
and no reads in the intra-isolate comparison, e.g. 1106a reads
aligned to the 1106a genome, exhibited the SNP or indel.
These criteria eliminated minor allele variants. Single base
errors in the 1106a and 1710b reference sequences were
identified when reads, and the underlying chromatograms, from
neither the primary nor the relapse isolates agreed with the
reference base (Table S5). We sequenced the 1710b isolate from
our strain collection using the Illumina Genome Analyzer and
aligned these reads to the 1710b reference sequence as
described previously. The alignment confirmed all errors listed
in Table S5.
Structural Variation
Structural variants within clonal pairs of isolates were identified
using large-insert genome analysis (LIGAN) technology based on a
fosmid cloning strategy as described in Hayden et al. [21]. Briefly,
deep fosmid libraries containing cloned inserts limited to
approximately 32 to 48 Kb in length were constructed in the
pCC1Fos vector (Epicentre, Madison, WI) for the isolates listed in
Table 1. For all isolates except 1026b (described previously),
fosmid end sequences and fingerprints using EcoRI, MluI and PstI
restriction enzymes were generated for approximately 1200
randomly picked clones. Fosmid data for each isolate were
analyzed independently using the Genomic Variation Analysis
(GenVal) suite of software tools (http://depts.washington.edu/
uwgcmed/software.html). GenVal determined positions for each
clone with respect to a given reference sequence and identified
locations of insertions, deletions and rearrangements based on
inconsistencies with normal fosmid tiling. For example, fosmids
spanning inversion breakpoints had paired-end sequences that did
not point toward each other and deletions in the query genome
were indicated when the apparent length of the anchored clone
was greater than the physical clone insert length based on
fingerprints (Figure 2). Fosmids for 1026a, 1106b and 1710a were
tiled against their complementary reference genomes for direct
primary-relapse strain comparison. Fosmids for the 354 and 1258
pairs were tiled against the 1026b and K96243 reference
sequences and variants unique to either the primary or relapse
isolate for each pair were identified.
Validation and Annotation of SNPs, Indels and Structural
Variation
All selected SNPs and indels were validated using Sanger
sequencing of PCR products (not shown). Structural variants were
confirmed and further characterized by shotgun sequencing of
selected fosmid clones as previously described [58]. For NS SNPs,
the effect of amino acid substitutions on protein function was
assessed using SIFT [33], which predicts whether a substitution is
tolerated based on sequence homology and the physical properties
of the amino acids.
SNP Discovery in BPSS1483 Homologs and Testing
Antibiotic Susceptibility
The sequence of BPSS1483 was obtained for 107 B. pseudomallei
strains (Table S6). The sequence was publicly available for eight
strains. DNA for 87 strains was provided by Don Woods
(University of Calgary, Alberta, Canada), and DNA for the
remaining twelve strains was isolated as described above. The gene
was PCR amplified and sequenced with the following primers:
CGACGATTTTCTCGAAGG (forward) and CGATTC-
GATTCCACGGTA (reverse). PCR amplifications were per-
formed using Phusion High-Fidelity DNA Polymerase and GC
Buffer (New England Biolabs, Inc., Beverly, MA) and included
10% DMSO. After an initial denaturation step at 98uC for 30 sec,
30 cycles of denaturation at 98uC for 10 sec, annealing at 60uC for
30 sec and extension at 72uC for 30 sec were carried out followed
by a final extension at 72uC for 5 min. Sequence reads were
aligned to BPSS1483 and evaluated for SNPs in Sequencher
(Gene Codes, Ann Arbor, MI). The effect of NS SNPs on protein
function was assessed using SIFT [33].
Two B. thailandensis mutants were selected from a comprehen-
sive, sequence-defined transposon mutant library (unpublished) for
antibiotic susceptibility testing. The library was constructed in the
reference B. thailandensis E264 strain using a conjugal plasmid
bearing a T8 transposon, which carries a tetracycline resistance
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sequencing of one of the transposon-genome junctions. The test
strain contained a transposon inserted into BTH_II0885, the
homolog of the BPSS1483 TetR gene, following nucleotide 200 of
1023 total nucleotides of the coding region. This insertion is within
the first fifth of the ORF and is thus likely to represent a null
mutation. The control strain contained a transposon in the
putative transposase gene BTH_I3273 and was used in place of
the wild-type strain to compensate for any phenotypic effect of the
antibiotic resistance gene carried by the transposon. The
transposon insertion sites in the test and control strains were
confirmed by re-sequencing single-colony purified cells.
Minimal inhibitory concentrations (MICs) were determined
using Etest gradient strips (AB Biodisk, Piscataway, NJ) following
manufacturer’s protocols. Assays of B. pseudomallei strains were
conducted in the BSL3 containment facility at the University of
Washington.
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